Susquehanna International Group, LLP Eloxx Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.4 - $0.72 $9,116 - $16,410	-22,792 Reduced 65.77%	11,860 $7,000
Q4 2021 Feb 14, 2022	SELL	$0.62 - $1.61 $6,443 - $16,731	-10,392 Reduced 23.07%	34,652 $25,000
Q3 2021 Nov 15, 2021	BUY	$1.22 - $2.0 $17,424 - $28,564	14,282 Added 46.43%	45,044 $73,000
Q2 2021 Aug 11, 2021	BUY	$1.35 - $3.36 $41,528 - $103,360	30,762 New	30,762 $61,000
Q1 2021 May 17, 2021	SELL	$3.02 - $4.54 $40,694 - $61,176	-13,475 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.42 - $4.48 $32,609 - $60,368	13,475 New	13,475 $54,000
Q1 2020 May 15, 2020	SELL	$1.96 - $7.96 $29,227 - $118,699	-14,912 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.19 - $7.56 $10,549 - $25,000	3,307 Added 28.5%	14,912 $110,000
Q3 2019 Nov 14, 2019	BUY	$4.37 - $9.91 $50,713 - $115,005	11,605 New	11,605 $52,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.